financetom
Business
financetom
/
Business
/
Vertex Energy Chief Operating Officer James Rhame to Retire
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vertex Energy Chief Operating Officer James Rhame to Retire
Jul 18, 2024 2:11 AM

04:46 AM EDT, 07/18/2024 (MT Newswires) -- Vertex Energy ( VTNR ) said late Wednesday its Chief Operating Officer James Rhame will retire from his position, effective July 25.

The company has appointed Chief Commercial Officer Doug Haugh as interim chief operating officer.

Rhame will continue in a consulting role at Vertex through the end of 2024, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Incyte Q3 Non-GAAP Earnings, Revenue Increase
Incyte Q3 Non-GAAP Earnings, Revenue Increase
Oct 28, 2025
07:28 AM EDT, 10/28/2025 (MT Newswires) -- Incyte ( INCY ) reported Q3 non-GAAP earnings Tuesday of $2.26 per diluted share, up from $1.07 a year earlier. Analysts polled by FactSet expected $1.58. Revenue for the quarter ended Sept. 30 was $1.37 billion, up from $1.14 billion a year earlier. Analysts surveyed by FactSet expected $1.25 billion. ...
Trump says he will meet Nvidia CEO on Wednesday
Trump says he will meet Nvidia CEO on Wednesday
Oct 28, 2025
TOKYO, Oct 28 (Reuters) - U.S. President Donald Trump said he would meet with Nvidia ( NVDA ) Chief Executive Jensen Huang on Wednesday. Trump made the comment Tuesday in an address to business leaders in Tokyo before traveling to South Korea. The U.S. AI chipmaker said last week that Huang plans to meet global leaders and top Korean executives...
Regeneron beats quarterly estimates on strong demand for Dupixent
Regeneron beats quarterly estimates on strong demand for Dupixent
Oct 28, 2025
Oct 28 (Reuters) - Regeneron Pharmaceuticals ( REGN ) beat Wall Street estimates for third-quarter results on Tuesday, helped by strong demand for its eczema treatment, Dupixent, and cancer treatment Libtayo, sending its shares up 5.6% premarket. Analysts said Dupixent, made by the U.S. drugmaker in partnership with Sanofi, continues to impress, after the drug topped quarterly sales expectations when...
Barclays to Acquire Leading U.S. Personal Loan Originator Best Egg
Barclays to Acquire Leading U.S. Personal Loan Originator Best Egg
Oct 28, 2025
WILMINGTON, Del., Oct. 28, 2025 /PRNewswire/ -- Barclays PLC (Barclays)1 today announces that its wholly-owned US consumer banking subsidiary Barclays Bank Delaware (operating as Barclays US Consumer Bank or USCB) has agreed to acquire Best Egg, Inc. (Best Egg or the Business)2 for $800 million3 (the Transaction). Completion of the Transaction (Completion) is subject to required regulatory approvals and other conditions....
Copyright 2023-2026 - www.financetom.com All Rights Reserved